While lysosomal dysfunction and sphingolipids are implicated in the development of Parkinson’s disease in patients with Gaucher disease and their first-degree relatives, no clear mechanistic pathway for GBA1-related Parkinson’s disease and Lewy body dementia has yet been established [35]. This evidence concerns the gene GBA1 and Gaucher disease.